e-therapeutics plc (LON:ETX – Get Free Report) shares traded up 1.1% on Tuesday . The stock traded as high as GBX 11.22 ($0.14) and last traded at GBX 9.60 ($0.12). 948,419 shares changed hands during mid-day trading, an increase of 31% from the average session volume of 722,249 shares. The stock had previously closed at GBX 9.50 ($0.12).
e-therapeutics Stock Down 6.7 %
The firm has a market cap of £52.59 million, a price-to-earnings ratio of -450.00 and a beta of 0.48. The business’s 50-day moving average is GBX 11.18 and its 200-day moving average is GBX 11.74. The company has a debt-to-equity ratio of 0.33, a quick ratio of 20.13 and a current ratio of 22.20.
About e-therapeutics
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.
Recommended Stories
- Five stocks we like better than e-therapeutics
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Arm’s Earnings Stumble Could Create A Golden Entry Point
- EV Stocks and How to Profit from Them
- How to Bet on a Large Stock Price Move with an Options Strangle
- What is the FTSE 100 index?
- Shopify Stock Took a Breather, Markets Stay Bullish On its Future
Receive News & Ratings for e-therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
